Investigating the therapeutic potential of

changing the dietary carbohydrate/fat-ratio to prevent cognitive decline and Alzheimer pathology
– A pilot study

FBHI is the sponsor of the  randomized clinical trial COGNIFOOD, which looks into the effects of macronutritional composition on cognitive function and associated biomarkers,

The study will target individuals with prodromal Alzheimer’s disease. An important aim of this pilot study is to assess the participants’ adherence to the study diets. Support will be given by the study team and a mandatory study partner.

COGNIFOOD will start in 2023 at the Karolinska University Hospital and is financed by the af Jochnick Foundation.

Main Collaborators

Karolinska University Hospital, Karolinska Institutet


af Jochnick Foundation